UMB BioPark biotech company Noxilizer expands to Europe

Biotech company Noxilizer, based out of the University of Maryland BioPark, has set up a sales operation in Europe.
The company, which “manufactures sterilization technology for medical devices and equipment,” announced in a press release that its expansion to Europe “is intended to accelerate the global acceptance of nitrogen dioxide sterilization as a powerful, efficient, and cost-saving alternative to traditional sterilization methods.”
Read more at Noxilizer.